solution was prepared by mixing the stock buffer (heptafluorobutyric acid solution) purchased from Beckman with acetonitrile and water in the proportion 0.25:0.65:9.1 (by vol). The column was thermoregulated at 37°C.
Convenient, Rapid Test for Lead in Blood with Use of
Disposable Electrodes, Elliot Plotkin, 1,2 * Jerome F. McAleer, 1, 2 M. Lucinda Cordeiro, 1 Martin R. Ackland, 1 Timothy M. Sheehan, 3 and Robin A. Braithwaite 3 ( 1 Ecossensors Ltd., 74 Sunderland Rd., Sandy Bedfordshire SG19 1QY, UK, and 3 Regional Lab. for Toxicol., City Hosp., Birmingham B18 7QH, UK; 2 present address and * address for correspondence: Inverness Medical Ltd., Beechwood Park North, Inverness IV2 3ED, UK, fax 44-1463-724601)
In recent years concern over the adverse effects of low concentrations of lead on children has increased. In 1991, the CDC reduced the acceptable blood lead concentration from 250 g/L to 100 g/L and recommended screening of all American children Ͻ6 years old for lead poisoning [1] . Graphite furnace atomic absorption spectroscopy is HPLC analysis was performed on a reversed-phase column at 37°C, with a flow rate of 1 mL/min and injection volume of 50 L. Fluorescence detection: ex ϭ 295 nm, em ϭ 395 nm.
the most common method of measuring lead in blood, but the CDC has encouraged the development of other methods that could be used for mass population screening or near-patient testing. Such methods should be portable, cheap, and easier to use than graphite furnace atomic absorption spectroscopy as recommended by CDC Program Announcement 269, 1992.
The electrochemical technique of stripping voltametry at a mercury electrode has also been used for blood lead analysis. Commercially available instruments based on this method have been used widely but have insufficient accuracy and precision for measuring lead at low concentrations [2] . Recently, improvements have been made in the electrochemical measurement of blood lead. Ostapczuk [3] and Jagner et al. [4] obtained good accuracy and precision at low concentrations by potentiometric stripping analysis. They used a mercury-coated graphite electrode that must be cleaned between each analysis, and their testing procedure required stirring of the acidified blood solution.
An approach to stripping analysis that simplifies the testing is the use of disposable electrodes, which can be used once and then thrown away. Microarray electrodes have properties that make them especially suitable for this application. They have high current densities in unstirred solution, have a high signal-to-background ratio, and are not affected by dissolved oxygen. Furthermore, they can be made cheaply by a combination of screen printing and laser photoablation (international patent WO 91/08474) [5] . In sufficiently large numbers, e.g., 10 6 electrodes per year, they could be manufactured for ϳ$1 each. Recently Feldman et al. [6] described the use of disposable microelectrode arrays for measuring lead in blood. Their testing protocol required that the electrodes be preplated with mercury. They also found that the electrodes responded differently to different blood types, and they had to use standard additions to determine the lead concentration.
Here we report a simplified procedure for the use of disposable microelectrodes to measure lead in blood. Mercury is not preplated or added to the test solution but is contained in a precoated layer on the electrode and coplates with the lead. These devices can be precalibrated, removing the need to perform standard additions.
The disposable electrodes were similar to those described by Feldman et al. [6] but also incorporated a carbon counterelectrode in addition to the Ag/AgCl reference electrode and carbon microelectrode array. Each 2 mm ϫ 3 mm array consists of 13 rows of 19 microelectrodes, each with a diameter of ϳ40 m. The electrodes were cleaned by soaking for 30 min in 0.1 mol/L HCl. A reagent layer containing ϳ11 g of mercury was inkjetted over each array with the use of a Bio Dot Microdoser. The ink-jetting solution contained 12.5 g/L mercuric nitrate, 15.4 g/L hydroxyethylethylenediaminetriacetic acid (HEDTA) (Aldrich), 30.0 g/L carboxymethylcellulose (CMC) (Aqualon), 1.0 g/L hydroxyethylcellulose (HEC) (Fluka), and 50 mmol/L KCl. The CMC and HEC are film-formers, and the HEDTA is a chelating agent that stabilizes the mercury (international patent application PCT/GB96/00301).
The procedure for performing a blood lead test involved two steps, acidification and electrochemical measurement. The initial acidification step involved the addition of 200 L of blood to 2.0 mL of 0.9 mol/L HCl in a 20-mL polystyrene vial. The vial was then mixed briefly by hand and put on a bottle roller for ϳ5 min to ensure complete release of the bound lead before the blood was tested. Earlier experiments showed that 1 min was sufficient for complete release, but results were unchanged for up to 45 min.
The electrochemical testing was carried out with an Autolab (EcoChemie) in the differential pulse mode. Acidified blood (75 L) was pipetted to a disposable electrode, and deposition was effected by polarizing the electrode at Ϫ800 mV for 165 s. The stripping sequence used a pulse amplitude of 50 mV, step 5 mV, pulse width 3 ms, and trough width 120 ms. Lead-stripping peak heights were measured with use of the Autolab software.
The linear response of the electrodes was tested by the addition of various amounts of Pb(NO 3 ) 2 (Aldrich AA standard) to portions of a blood sample to give a range of lead concentrations up to 1000 g/L. The exact lead concentration of each supplemented blood sample was measured by atomic absorption. Each blood was tested with 5 disposable electrodes. A graph of peak current against lead concentration was linear up to ϳ600 g/L with a slope of 0.0070 A per g/L and an intercept of 0.212 A. The intercept may result from the presence of lead in the mercury layer on the electrodes. This graph was used as a calibration curve for subsequent electrodes.
Blood samples were selected from those sent to the Regional Toxicology Laboratory for clinical investigation or occupational monitoring of lead exposure [7] . In the majority of cases the specimens had been anticoagulated with potassium EDTA, although some pediatric samples had been collected into Li heparin. All the specimen collection tubes used were known to be free of lead contamination.
Blood lead was measured by electrothermal atomic absorption spectroscopy with the use of a Varian Spectra AA 44 spectrophotometer equipped with deuterium background correction and a GTA-96 graphite furnace (Varian UK). Blood was assayed directly after suitable dilution with an ammonium nitrate/ammonium phosphate modifier solution, with calibration against matrix-matched calibrators. Batch accuracy was monitored by the use of blood reference materials with accurately assigned values [7] (UK Supra Regional Assay Service Trace Elements Laboratories). Laboratory performance was assessed by participation in two national external quality-assessment schemes: NEQUAS lead and cadmium in blood (Wolfson EQA Laboratories) and TEQAS Trace Elements (Robens Institute, University of Surrey, Guildford).
The accuracy of the electrodes was determined by doing a correlation study with 20 venous blood samples, the lead concentrations of which had been determined as described above. Each blood was tested with 2 electrodes.
The lead concentrations were calculated from the leadstripping peaks with the use of supplemented blood calibration. The results of the correlation study ( Fig. 1) show an excellent agreement between the disposable electrodes and the comparison method. All 40 measurements were within 20 g/L of the comparison method results. Of the 22 measurements on blood samples with lead concentrations Ͻ200 g/L, 21 of them were within 10 g/L of the comparison method result. The low intercept and slope close to 1 demonstrate that the supplemented blood calibration works well.
The precision of the electrodes was tested with 3 venous blood samples with lead concentrations of 50, 110, and 250 g/L. Each blood sample was acidified once, and the solution was tested with 10 electrodes. The observed CV was 11.9%, 7.2%, and 2.7%, respectively.
In this electrochemical method of measuring lead in blood by disposable electrodes, a minimum of sample preparation and the use of precalibrated electrodes should enable relatively unskilled people to use this method for screening purposes. Although this lead test was carried out with 200-L venous samples, smaller volumes, which would enable fingerstick samples to be tested, could be used. The method is sufficiently accurate and precise to meet guidelines recommended by the CDC (Program Announcement 269, 1992). This technique might also have application in surveys of blood lead concentrations in lead-exposed remote populations in developing countries where laboratory facilities are not available.
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Improved Therapeutic Drug Monitoring of Tacrolimus (FK506) by Tandem Mass Spectrometry, Paul J. Taylor, 1,2* Nicholas S. Hogan, 2 Stephen V. Lynch, 3 Anthony G. Johnson, 1, 2 The immunosuppressant drug tacrolimus (FK506), which exhibits 50 -100 times the potency of cyclosporin A, is proving to be highly effective in preventing rejection in solid-organ transplantation [1] . However, because of a narrow therapeutic range, variable pharmacokinetics, and potential drug interactions, continual therapeutic drug monitoring (TDM) of tacrolimus is essential [2] . Recently, we published a report that detailed the development of a specific, sensitive method for quantification of tacrolimus concentrations in blood [3] . This methodology, which utilizes HPLC in combination with tandem mass spectrometry (LC-MS 2 ), was found to have greater specificity, lower detection limits, and a more rapid turnaround time than existing immunoassays. These attributes make this methodology ideal for TDM of tacrolimus.
Since our initial report, several modifications that have further improved the assay for TDM have been implemented. The use of a 100 ϫ 2 mm C 8 column (rather than a 30 ϫ 2 mm C 4 column), combined with a higher flow rate (400 L/min, compared with 100 L/min) and postcolumn splitting, has reduced the chromatographic assay time from 4 to 2 min. Although the retention times of the analytes are similar with both methods, intermittent late-eluting peaks observed previously are no longer present, allowing shorter analysis time. In addition, the use of a single point calibrator (i.e., linear through zero) at 10.0 g/L and two internal quality controls (5.0 and 20.0 g/L), compared with a seven-point calibration curve and three internal quality controls, has reduced the analysis time further. Previously, we reported an overall turnaround time of 2.5 h for a batch of 20 samples (10 patient samples). The modified method allows an analysis Fig. 1 . Correlation between blood lead determined by disposable microelectrodes and by the atomic absorption method.
Duplicate measurements were made on 20 venous blood samples.
